Type of Cancer: Breast Cancer
Sponsor: Sanofi
Phase / Design: A Randomized, Multicenter, Double-blind, Phase 3 Study for the Treatment of Patients with ER (+), HER2 (-) Breast Cancer who have not Received any Prior Systemic Anti-Cancer Treatment for Advanced Disease”
Population: